Our virtual panels include over 3,000 genes selected based on the most up-to-date literature, gene reviews and variant databases. Our whole genome approach offers cost-effectiveness by reducing the need for multiple targeted tests, and maximises diagnostic yield by allowing you to combine panels, select individual genes, and surface variants across all regions of the genome.
Genetics in Gastroenterology
Genetic testing has emerged as a valuable tool in the field of gastroenterology, offering critical insights into the genetic basis of various gastrointestinal conditions.
It is instrumental in diagnosing hereditary gastrointestinal disorders such as hereditary hemochromatosis, familial adenomatous polyposis (FAP), Lynch syndrome, and hereditary pancreatitis. It helps identify specific genetic mutations responsible for these conditions, enabling early and accurate diagnoses.
In the management of inflammatory bowel disease (IBD), knowledge of a patient’s genetic profile can help determine the most suitable medications and predict their likely response to treatment, thereby optimizing therapy and minimizing side effects. Genetic testing is valuable in the management of liver diseases, including hereditary hemochromatosis and Wilson’s disease. Early identification of genetic mutations associated with these conditions allows for timely interventions and monitoring to prevent complications.
While genetic panel tests are highly valuable in cardiology, it’s essential to interpret their results in the context of a patient’s clinical presentation and other diagnostic tests. We recommend working closely with genetic counselors and other specialists to ensure that genetic information is used effectively to diagnose, treat, and manage cardiology conditions.
For further information on tailoring treatment plans to an individual’s genetic profile, leading to improved outcomes and reduced side effects, please visit our pharmacogenomics page.